Ipilimumab/NivolumabAutoimmune-hepatitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72276-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：167 / 167

相关论文

共 50 条

[21] Ipilimumab/NivolumabAutoimmune colitis and pseudoprogression: case report
Reactions Weekly, 2025, 2045 (1) : 201 - 201
[22] Ipilimumab/nivolumabAutoimmune haemolytic anaemia: case report
Reactions Weekly, 2020, 1814 (1) : 189 - 189
[23] Ipilimumab/nivolumabAutoimmune colitis, acute interstitial nephritis and autoimmune hepatitis: case report
Reactions Weekly, 2021, 1882 (1) : 253 - 253
[24] Ipilimumab/nivolumabAutoimmune hypophysitis and hypoadrenocorticism: case report
Reactions Weekly, 2017, 1680 (1) : 190 - 190
[25] NivolumabAutoimmune hepatitis: case report
Reactions Weekly, 2018, 1716 (1) : 213 - 213
[26] Ipilimumab/nivolumabAutoimmune disorders and exanthema: case report
Reactions Weekly, 2019, 1754 (1) : 201 - 201
[27] NivolumabAutoimmune hepatitis: case report
Reactions Weekly, 2017, 1668 (1) : 302 - 302
[28] Ipilimumab/nivolumabAutoimmune diabetes, hypophysitis and itching: case report
Reactions Weekly, 2018, 1721 (1) : 161 - 161
[29] NivolumabAutoimmune cholestatic hepatitis: case report
Reactions Weekly, 2024, 2025 (1) : 380 - 380
[30] Ipilimumab/nivolumabAutoimmune demyelinating polyneuropathy and myasthenia gravis: case report
Reactions Weekly, 2022, 1917 (1) : 322 - 322

← 1 2 3 4 5 →